EMH will be down to $40M MC at this rate. Despite my own predictions associated with SP movement in the case a of a DFS delay it is hard to swallow the impact when it is actually materialised. The .3XX-.4XX SP assumption 'if the DFS is not released' is proving painfully accurate.
CRMA /Strategic Projects/Just Transition Fund news is the only short term SP growth catalyst that EMH may see in the next quarter. A bit bitter to see that EMH has failed to actually do anything that was in their control to preserve its SP, lets see if the random industry / external news can support the SP.
Worst case EMH will skim .2XXs in the next 2 months on the lack of news and gradual retail-exit. It is kind of funny that 3 years ago I was thinking that those who were 'in early' were so lucky to purchase in .2XX and-.4XX range, little did I know that in 2024 the SP would be -70% and such opportunities would be rampant.
- Forums
- ASX - By Stock
- EMH
- Ann: Cinovec Definitive Feasibility Study to be Completed Q1 2024
EMH
european metals holdings limited
Add to My Watchlist
3.03%
!
17.0¢

Ann: Cinovec Definitive Feasibility Study to be Completed Q1 2024, page-44
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $35.26M |
Open | High | Low | Value | Volume |
16.0¢ | 17.0¢ | 15.5¢ | $6.923K | 42.04K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3321 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 21973 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3321 | 0.155 |
2 | 53000 | 0.150 |
2 | 51500 | 0.145 |
1 | 17858 | 0.140 |
2 | 19099 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 21973 | 2 |
0.190 | 12100 | 2 |
0.195 | 2000 | 1 |
0.200 | 666 | 1 |
0.205 | 100000 | 1 |
Last trade - 15.52pm 27/06/2025 (20 minute delay) ? |
Featured News
EMH (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online